Receipt of R&D tax credit

/**/

RNS Number : 3002M CAP-XX Limited 19 December 2025  

19 December 2025 CAP-XX Limited ("CAP-XX" or "the Company") Receipt of R&D tax credit CAP-XX Limited (AIM: CPX), a global leader in supercapacitor technology, is pleased to announce that, further to the Company's announcement of 7 November 2025, the Australian Tax Office has approved the Company's R&D tax credit of A$1.75m and these funds have been received by the Company. The Company's current cash position is A$2.97m. For further information contact: CAP-XX Limited Dr Graham Cooley (Chairman)                                                                            +61 (2) 9157 0000 Lars Stegmann (Chief Executive Officer)   Allenby Capital (Nominated Adviser and Broker) David Hart/Piers Shimwell (Corporate Finance)                                                    +44 (0) 20 3328 5656 Jos Pinnington/Tony Quirke (Sales and Corporate Broking)   Notes to Editors: CAP-XX (LSE: CPX) is a leader in the design and manufacture of thin, flat supercapacitors and energy management systems used in portable and small-scale electronic devices, and to an increasing extent, in larger applications such as automotive and renewable energy. The unique feature of CAP-XX supercapacitors is their very high-power density and high energy storage capacity in a space-efficient prismatic package. These attributes are essential in power-hungry consumer and industrial electronics and deliver similar benefits in automotive and other transportation applications. For more information about CAP-XX, visit www.cap-xx.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.  END  MSCEAEANFFESFFA